Enhancing the levels of pregnenolone, DHEA, and their sulfate forms, as well as modulating enzymes like CYP11B1 and AKR1C3, could help mitigate inflammation and neurodegeneration associated with MS. Here, CYP11B1 is linked to myeloid sarcoma.